))
The Future of Biopharmaceuticals with Jesse McCool
Manage episode 448567261 series 3601217
Sisällön tarjoaa Kelly Science Engineering Technology & Telecom and Kelly Science Engineering Technology. Kelly Science Engineering Technology & Telecom and Kelly Science Engineering Technology tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Jesse McCool, the visionary Co-Founder and CEO of Wheeler Bio, joins host Hugo Malan on this episode of ReSETTing Tomorrow to reveal the future of biopharmaceuticals. Wheeler Bio is a pioneering biomanufacturing company dedicated to accelerating therapeutic innovation into clinical impact. Founded in 2021 by Jesse alongside industry veterans Christian Kanady and Errik Anderson, Wheeler Bio is revolutionizing the way we approach drug development, bridging the crucial gap between discovery and clinical supply for biologics. In their conversation, Hugo and Jesse uncover the driving force behind Wheeler Bio's inception, explore their groundbreaking Portable CMC® platform, and learn how their unique partnering model is reshaping the landscape of biopharmaceuticals. From democratizing access to comprehensive discovery-to-IND programs, to providing best-in-class services for biologics innovators, Wheeler Bio is at the forefront of driving transformative change in the industry. So, hit that play button and prepare to be inspired by Jesse McCool and Wheeler Bio.
Follow Us
Presented by Kelly Science, Engineering, Technology & Telecom
https://SET.KellyServices.us/
7 jaksoa
Jaa
